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Summary
Aims:  Surgery  is  the  only  available  curative  treatment  option  following  failure  of  radiation  ther-
apy for  oropharyngeal  cancer.  This  study  was  designed  to  analyse  the  postoperative  morbidity
and survival  rate  in  patents  undergoing  salvage  surgery.
Material  and  methods:  Single-centre  retrospective  study  in  a  tertiary  referral  centre.
Results: One  hundred  and  ﬁve  patients  were  included,  with  tumour  recurrence  in  72  cases,
and disease  progression  in  33  cases,  despite  radiotherapy.  Seventy-seven  tumours  were  located
in the  tonsillar  fossa  or  glossotonsillar  sulcus.  Ninety-four  tumours  were  classiﬁed  as  rT2-T3
and 83  were  classiﬁed  as  rN0.  Segmental  mandibulectomy  was  performed  in  77  cases.  Cervical
lymph node  dissection  was  performed  in  96  cases.  Pharyngeal  reconstruction  was  performed
with a  myocutaneous  ﬂap  in  90  cases.  Forty-one  local  complications  were  observed,  including
12 orocutaneous  ﬁstulae  and/or  neck  abscesses,  associated  with  carotid  artery  rupture  in  three
cases. Twenty  patients  experienced  general  complications.  The  mean  decannulation  and  feeding
times were  20  and  30  days,  respectively.  The  5-year  disease-free  survival  was  21%.  On  univariate
analysis, survival  was  poorer  in  patients  with  disease  progression  (P  =  0.01);  survival  was  also
correlated  with  tumour  site  (P  =  0.02),  rT  status  (P  =  0.03),  rN  (P  =  0.048),  and  quality  of  resection
(P =  0.04).  On  multivariate  analy
radiotherapy  and  surgery  (P  =  0.
Conclusion:  The  results  of  this  s
for oropharyngeal  cancer  and  th
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tudy  conﬁrm  the  high  local  complication  rate  of  salvage  surgery
e  poor  overall  survival.
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Table  1  rTN  classiﬁcation.
rT
rN  0  1  2  3  Total
1  8  1  1  —  10  (9.5%)
2 35  4  —  1  40  (38%)
3 39  10  5  —  54  (51.5%)
4 1  —  —  —  1  (1%)
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ntroduction
adiotherapy  and  surgery  are  the  two  reference  treatments
or  oropharyngeal  cancer.  Surgery  is  the  only  curative  treat-
ent  option  available  after  failure  or  recurrence  after
adiotherapy  [1].  Surgery  of  the  lateral  oropharynx  has
volved  considerably  since  the  transmandibular  pharyngec-
omy  described  and  developed  in  the  1950s  by  Dargent  [2].
his  technique  is  still  used  in  the  salvage  setting  but  has
ndergone  a  number  of  technical  improvements:
 preservation  of  the  mandible,  resulting  in  better  func-
tional  and  cosmetic  results  [3];
use  of  myocutaneous  pedicle  ﬂaps  [4].
Despite  these  improvements,  surgery  after  radiotherapy
s  associated  with  two  main  difﬁculties:
delayed  healing  responsible  for  local  complications;
local  disease  control  which  determines  patient  survival.
This  study  was  designed  to  analyse  the  postoperative
orbidity  and  survival  of  patients  operated  for  oropharyn-
eal  cancer  after  radiotherapy.
aterial and methods
his  single-centre  retrospective  study  (1980—2005)  was  con-
ucted  in  a  tertiary  referral  centre.  Inclusion  criteria  were:
presence  of  biopsy-conﬁrmed  recurrence  of  oropharyn-
geal  cancer  (invasive  squamous  cell  carcinoma),  with  no
synchronous  tumours  or  metastases;
treatment  by  mandibulectomy  with  systematic  frozen
section  histological  examination.
The  rTN  classiﬁcation  and  staging  were  performed
ccording  to  the  UICC  2002  classiﬁcation  [5].  All  patients  had
een  initially  treated  for  oropharyngeal  cancer  by  curative
oses  of  radiotherapy;  patients  previously  treated  by  radio-
herapy  for  a  primary  cancer  with  a  metachronous  tumour
ituated  in  the  oropharynx  were  excluded.  Ordinal  variables
ere  compared  by  Fisher’s  exact  test.  Survival  estimates
ere  calculated  by  the  Kaplan-Meier  method  and  survivals
ere  compared  by  a  Log-rank  test;  multivariate  analysis  was
erformed  according  to  the  Cox  model  (Statview  5.1).
esults
ne  hundred  and  ﬁve  patients  (93  men  and  12  women,  with
 mean  age  of  59  years)  were  included  in  this  study.  Fifty-
ve  had  been  operated  before  1995.  Seventy-three  patients
ad  been  initially  treated  in  another  centre  and  the  initial
TNM  classiﬁcation  was  available  for  only  30  (41%)  of  them.
ixty  (57%)  patients  had  not  stopped  smoking  and/or  drink-
ng.  Eighteen  patients  had  grade  2  arterial  disease  of  the
ower  limbs,  15  had  type  II  diabetes,  and  12  were  treated
or  chronic  obstructive  pulmonary  disease  (COPD).
The  mean  radiation  dose  delivered  to  the  tumour  was
0  Grays  with  58  Grays  delivered  to  the  ﬁrst  draining  lymph
3
t
p
TTotal 83  (79%)  15  (14.5%)  6  (5.5%)  1  (1%)  105
odes.  Thirty-three  (32%)  patients  presented  disease  pro-
ression  and  72  (68%)  presented  recurrence  with  a  mean
nterval  between  radiotherapy  and  recurrence  of  22  months.
Tumour  sites  were:
 tonsillar  fossa,  48  cases;
glossotonsillar  sulcus,  29  cases;
base  of  tongue,  20  cases;
retromolar  trigone  and/or  intermaxillary  commissure,
8  cases.
The  tumour  was  ulcerated  and/or  invasive  in  84  cases.
he  rTN  classiﬁcation  is  shown  in  Table  1.  Ninety-four
umours  were  classiﬁed  as  rT2-T3.  No  lymphadenectomy
ere  detected  clinically  and/or  radiologically  in  83  cases.
here  were  eight  stage  I,  35  stage  II,  54  stage  III  and  eight
tage  IV  tumours.
Segmental  mandibulectomy  was  performed  in  77  (74%)
atients  and  marginal  mandibulectomy  was  performed  in
8  patients.  Unilateral  lymph  node  dissection  was  performed
n  96  (95%)  patients  with  radical  neck  dissection  in  73  cases
nd  modiﬁed  radical  neck  dissection  in  23  cases.  No  lymph
ode  dissection  was  performed  in  nine  patients  who  had  all
ndergone  dissection  as  part  of  the  initial  treatment,  prior
o  radiotherapy.  In  80  cases  (86%),  pharyngeal  reconstruction
as  performed  with  a pectoralis  major  or  latissimus  dorsi
yocutaneous  ﬂap  (MCF).  A  temporofrontal  ﬂap  was  used  in
0  patients  operated  before  1983.  The  pharynx  was  closed
y  direct  suture  in  ﬁve  cases  (5%)  due  to  minimal  loss  of
ubstance  associated  with  a  small  tumour  recurrence  (rT1).
ight  (7.5%)  patients  received  adjuvant  therapy  according
o  the  protocol  proposed  by  Wong  et  al.  [6]  with  a  com-
ination  of  5-ﬂuorouracil  and  hydroxyurea  alternating  with
adiotherapy  sessions  for  four  to  six  cycles.
ostoperative  course
he  mean  hospital  stay  (excluding  postoperative  deaths)  was
0  days.  The  mean  decannulation  time  was  20  days.  Seven
atients  could  not  be  weaned  of  their  tracheotomy  and  were
xcluded  from  calculation  of  the  mean  decannulation  time.
he  mean  time  to  resumption  of  satisfactory  oral  feeding
1,500  kcal/24  hours  —  removal  of  the  nasogastric  tube)  was
0  days.  Three  patients  required  a  transient  feeding  gastros-
omy  (for  an  average  of  3  months);  four  patients  required
ermanent  gastrostomy  due  to  major  swallowing  disorders.
hese  seven  patients  were  excluded  from  calculation  of  the
Salvage  surgery  after  radiotherapy  for  oropharyngeal  cancer  e13
Table  2  Local  and  general  complications.
Complications  Number  %
Local
Orocutaneous  ﬁstula  and/or  neck
abscess
12a 11.5
Partial  ﬂap  necrosis  and/or  partial
wound  dehiscence
24b 23
Cervical  skin  necrosis  5  4.5
Total 41  39
General
Pneumonia 10 9.6
Decompensation  of  diabetes 5 4.8
Pulmonary  embolism  3  2.8
Gastrointestinal  haemorrhage  1  0.9
Stroke 1  0.9
Total 20 19
a Anaerobic bacteria isolated in eight cases (ﬁve fusobac-
terium/three E. coli).
Table  3  Lymph  node  histological  status  according  to  the  rN
classiﬁcation.
pN  rN0  rN1  rN2  rN3  Total
N-  53  11  2  0  66
N+/R- 10  0  1  0  11
N+/R+ 11  4  3  1  19
Total 74  15  6  1  96
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ob Combination of orocutaneous ﬁstula and/or neck abscess in
10 cases.
mean  time  to  resumption  of  oral  feeding.  Two  of  the  four
patients  with  permanent  gastrostomy  also  belonged  to  the
group  of  non-extubated  patients.
Local  and  general  complications  are  summarized  in
Table  2.  Complications  were  distributed  homogeneously
throughout  the  study  period.  Three  of  the  patients  with
a  general  complication  died.  Three  patients  with  a neck
abscess  died  from  rupture  of  the  carotid  artery  on  D17,
D23,  and  D40,  respectively.  Pharyngeal  closure  had  been
performed  by  direct  suture  in  one  patient  and  by  pec-
toralis  major  MCF  in  the  other  two  patients.  Thirty
patients  required  surgical  revision,  for  orocutaneous  ﬁstula
in  12  cases  and  partial  necrosis  and/or  partial  wound  dehis-
cence  in  18  cases;  healing  was  achieved  by  local  wound  care
in  11  patients:  six  cases  of  partial  necrosis  of  the  MCF  and
ﬁve  cases  of  cervical  skin  necrosis.
Oncological  results
Histological  examination
Tumour  resection  was  considered  to  be  incomplete  on  deﬁni-
tive  histological  examination  in  42  patients  (40%).  Surgical
margins  were  less  than  5  mm  on  one  of  the  sections  in
22  cases  (21%)  and  at  least  one  section  was  invaded  (R1)  in
20  cases  (19%).  The  sites  of  invaded  sections  were:
•  tongue  muscles,  21  cases;
•  vallecular  mucosa,  14  cases;
•  palatal  mucosa,  ﬁve  cases;
•  mucosa  of  the  maxillary  tuberosity,  two  cases.
Fungating  tumours  were  completely  resected  in  95%  of
cases,  versus  only  46%  of  invasive  and/or  ulcerated  tumours.Table  3  shows  histological  lymph  node  invasion  (pN+)
according  to  rN  classiﬁcation.  Lymph  node  dissection  was
not  performed  in  nine  patients.  Thirty  patients  (31%)  were
classiﬁed  as  pN+.  Of  the  74  patients  with  no  clinically  or
a
w
apN: histological lymph node status; N−: no lymph node inva-
sion; N+: presence of lymph node invasion; R−: No lymph node
effraction; R+: presence of lymph node effraction.
adiologically  detectable  lymph  nodes  (rN0),  21  (28%)  were
N+.
Bone  invasion  was  speciﬁed  for  only  61  of  the
7  segmental  mandibulectomies;  bone  was  invaded  in  nine
ases  (14.7%),  corresponding  to  tumours  located  in  the
etromolar  trigone,  intermaxillary  commissure,  or  glosso-
onsillar  sulcus.
auses  of  death  and  survival
he  mean  follow-up  was  44  months.  No  patient  was  lost  to
ollow-up.  Eighty-four  patients  had  died  at  the  end  of  follow-
p.  The  causes  of  death  were:
 carotid  artery  rupture,  three  cases;
 gastro-intestinal  haemorrhage  and  pulmonary  embolism,
one  and  two  cases,  respectively;
 local  tumour  recurrence,  44  cases;
 lymph  node  recurrence,  seven  cases;
 lymph  node  and  local  tumour  recurrence,  eight  cases;
 one  or  several  metastases,  six  cases;
 metachronous  cancer,  11  cases;
 intercurrent  causes  (stroke,  myocardial  infarction),  two
cases.
The  perioperative  mortality  rate  was  therefore  6%,  the
ocal  control  rate  was  46.5%  and  the  regional  control  rate
as  37%.  Five  of  the  patients  who  died  from  metastatic  dis-
ase  also  presented  tumour  and/or  lymph  node  progression.
etastatic  sites  were:
 lungs;  ﬁve  cases;
 lungs  and  liver,  one  case.
Metachronous  sites  were:
 hypopharynx,  ﬁve  cases;
 oesophagus,  three  cases;
 bronchus,  three  cases.
The  mean  time  to  onset  of  metachronous  cancer  was
8  months.  Only  one  patient  with  lung  cancer  was  able  to  be
perated,  but  died  immediately  postoperatively  in  a  context
f  acute  respiratory  distress  syndrome.The  disease-free  survival  was  52%  at  1  year,  31%  at  3  years
nd  21%  at  5  years  (Fig.  1).  On  univariate  analysis,  survival
as  poorer  for  patients  with  disease  progression  (P  =  0.01)
nd  was  also  correlated  with  tumour  site  (P  =  0.02),  rT  status
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Figure  1  Cumulative  survival  graph  for  survival  without
relapse  (Kaplan-Meier);  data  for  censorship:  a  live  without
relapse.
Table  4  Survival  rate  as  a  function  of  signiﬁcant  prognostic
factors.
Variables 1  year
(%)
3  years
(%)
5  years
(%)
Pa
Recurrence 65  40  35  0.01
Disease  progression  39  22  5
TF +  RMT  +  IMC  72  50  37  0.02
GTS +  BT  50  22  10
rT1-T2  70  47  36  0.03
rT3-T4 51  22  11
pN− 67  37  21  0.048
pN+ 40  20  12
Complete  resection 73 37 23 0.04
Incomplete  resection 49 17 10
TF: tonsillar fossa; RMT: retromolar trigone; IMC: intermaxillary
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mcommissure; GTS: glossotonsillar sulcus; BT: base of tongue.
a Limit of signiﬁcance = 0.05.
P  =  0.03),  rN  (P  =  0.048),  and  quality  of  resection  (P  =  0.04)
Table  4).  On  multivariate  statistical  analysis,  tumour  size
P  =  0.03)  and  the  interval  between  the  end  of  radiotherapy
nd  surgery  (P  =  0.02)  were  the  main  prognostic  factors  for
urvival.
iscussion
n  eight  patients,  the  tumour  was  located  in  the  intermaxil-
ary  commissure  or  retromolar  trigone.  Anatomically,  these
wo  sites  are  part  of  the  oral  cavity,  but  are  situated  at
he  frontier  between  the  oral  cavity  and  the  oropharynx
nd  it  is  sometimes  difﬁcult,  according  to  the  extent  of
he  tumour,  to  precisely  determine  to  which  region  these
umours  belong.  Strictly  speaking,  in  terms  of  the  objectives
f  this  study,  these  patients  should  have  been  excluded.
evertheless,  in  view  of  the  number  of  patients  concerned,
xclusion  of  these  cases  would  not  have  signiﬁcantly  modi-
ed  the  results.  This  study  was  based  on  a  25-year  period,
s
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hich  probably  introduced  a  certain  bias  in  the  results,  as
onsiderable  progress  has  been  made  in  surgical  techniques
nd  perioperative  care  between  1980  and  2005.  However,
he  local  and  general  complication  rate  did  not  vary  over
ime,  but  this  is  a  retrospective  study  comprising  the  biases
nherent  to  this  type  of  study.  Sociodemographic  data  and
he  number  of  smokers  and  drinkers  in  the  study  popula-
ion  are  comparable  to  the  ﬁgures  reported  in  the  literature
7].  The  percentage  of  patients  with  a  stage  III-IV  tumour
as  similar  to  that  reported  in  the  literature,  with  a  patient
ohort  similar  to  our  series  [8—10]. The  initial  cTNM  dis-
ribution  could  not  be  compared,  as  this  information  was
issing  in  more  than  one  third  of  cases  in  this  series.  Sur-
ival  could  also  not  be  compared  according  to  the  date  of
reatment.  Although  one  half  of  patients  were  operated
efore  and  after  1995,  the  rTN  distribution  was  not  equiva-
ent,  preventing  comparison  of  survivals  between  these  two
eriods.
There  is  a  consensus  in  the  literature  to  reserve  radio-
herapy  to  fungating  tumours  of  the  lateral  wall  of  the
ropharynx,  situated  away  from  the  mandibular  bone,  and
o  propose  surgery  for  invasive  or  juxtaosseous  tumours
11]:  retromolar  trigone,  intermaxillary  commissure,  glos-
otonsillar  sulcus.  Tumour  size  and  N  stage  are  also  major
eterminants  with  better  local  control  rates  for  small
umours  (T1-T2)  with  no  cervical  lymph  nodes  (N0)  [12].
he  mean  rates  of  tumour  progression  or  local  recurrence
fter  radiotherapy  are  20%  for  T1-T2  tumours  and  35%  for
3-T4  tumours  [12,13].  In  the  majority  of  cases,  tumour
ecurrence  is  diagnosed  during  the  ﬁrst  2  years  following  the
nd  of  treatment  [14], as  in  our  series.  Salvage  surgery  is
he  only  treatment  that  can  be  proposed  to  these  patients,
ut  this  surgery  is  not  always  possible.  According  to  Nichols
t  al.,  the  tumour  was  considered  to  be  unresectable  after
adiotherapy  in  14%  of  cases  [15].
The  two  main  problems  encountered  after  salvage
andibulectomy  in  irradiated  tissues  are  healing  disorders
ssociated  with  a  high  local  complication  rate  and  poor  local
isease  control.  In  this  series,  the  mandible  was  preserved
n  only  26%  of  cases  versus  80%  of  cases  for  primary  surgery,
n  our  experience  (unpublished  results).  Similar  data  have
een  reported  in  the  literature.  Contrast-enhanced  CT  is
he  imaging  modality  most  often  performed  to  assess  local
xtension  before  surgery  for  cancer  of  the  lateral  wall  of
he  oropharynx.  CT  has  a variable  sensitivity  (53  to  92%)  and
peciﬁcity  (83  to  96%)  to  evaluate  bone  invasion.  In  com-
ination  with  FDG  PET,  CT  has  a  sensitivity  of  100%,  while
he  speciﬁcity  remains  85%  [16]. The  sensitivity  and  speci-
city  of  MRI  are  slightly  lower,  93  and  82%,  respectively,  but
evertheless  higher  than  those  of  CT  alone  [17]. After  radio-
herapy,  the  tissue  changes  induced  by  the  tumour  and/or
nﬂammation  around  the  tumour  make  interpretation  of
maging  very  difﬁcult  in  terms  of  potential  bone  invasion,
xcept  in  the  case  of  massive  osteolysis  regardless  of  the
maging  modality.  No  publication  speciﬁcally  dealing  with
his  subject  was  found  in  the  literature.  Mandibular  invasion
as  observed  in  14.7%  of  cases  in  this  series,  indicating  that
andible-preserving  surgery  is  theoretically  possible  in  the
alvage  setting  for  tumours  situated  away  from  the  retromo-
ar  trigone,  intermaxillary  commissure,  and  glossotonsillar
ulcus.  However,  the  contribution  of  the  various  imaging
odalities  for  assessment  of  mandibular  bone  invasion  after
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radiotherapy  must  be  evaluated  in  order  to  limit  the  number
of  radical  surgical  procedures.
A  ﬂap  was  used  for  pharyngeal  closure  in  95%  of  cases,
with  a  majority  of  pectoralis  major  myocutaneous  ﬂaps.
After  2001,  most  of  these  ﬂaps  were  harvested  without  a  skin
paddle,  allowing  more  satisfactory  muscle-to-mucosa  appo-
sition  in  the  case  of  a  large  adipose  layer  [4]  at  the  price  of
more  marked  retraction  of  the  zone  ﬁlled  by  the  ﬂap  after
healing,  with  no  negative  functional  consequences.  Flaps
were  used  for  closure  in  a  higher  proportion  of  patients
in  this  series  than  in  published  series  with  a  comparable
number  of  operated  patients  [8—10]: 11  to  43%.  This  higher
ﬂap  rate  was  not  due  to  a  higher  percentage  of  stage  III-IV
tumours,  which  was  essentially  comparable  to  that  of  the
literature,  but  to  a  deliberate  choice  of  surgical  technique.
Some  teams  use  free  ﬂaps,  mostly  a  fasciocutaneous  ﬂap
(forearm  ﬂap)  for  pharyngeal  reconstruction  in  the  absence
of  mandibular  resection  or  a  composite  ﬂap  (ﬁbula  ﬂap)  in
the  case  of  associated  bone  resection;  the  local  complica-
tion  rate  (necrosis  and/or  wound  dehiscence)  is  situated
between  35  and  40%  [18].
The  high  rate  (28%)  of  histological  lymph  node  invasion  in
cN0  patients  supports  systematic  neck  dissection  ipsilateral
to  the  pharyngeal  tumour.
The  nature  and  frequency  of  general  complications  cor-
respond  to  those  usually  reported  after  surgery  for  head
and  neck  cancer;  these  complications  are  related  to  comor-
bidities,  especially  cardiorespiratory  disease.  The  all-cause
perioperative  mortality  rate  was  globally  identical  in  the
various  published  series,  with  an  average  of  7%,  in  line
with  our  series  (6%)  [9,13]. This  mortality  rate  is  twice  that
reported  after  primary  surgery  (3%)  for  all  head  and  neck
cancer  sites  [19]  and  ﬁvefold  higher  than  the  mortality  rate
associated  with  oropharyngeal  cancer  alone  (mean:  1.5%)
[10,11].  This  difference  can  be  explained  by  decompensa-
tion  of  comorbid  conditions  and  the  high  rate  of  carotid
artery  rupture  of  up  to  11%  [8],  although  this  rate  has  been
signiﬁcantly  reduced  by  the  use  of  MCF  [8,20,21].  The  low
rate  of  carotid  artery  rupture  (3%)  in  our  series  was  probably
related  to  the  almost  systematic  use  of  ﬂap  reconstruction.
The  main  risk  factor  for  carotid  artery  rupture  is  delayed
local  healing,  in  the  presence  or  absence  of  orocutaneous  ﬁs-
tula  and/or  abscess.  Carotid  artery  rupture  can  be  delayed,
sometimes  occurring  several  weeks  after  the  operation  [9].
In  our  series,  a  pectoralis  major  MCF  was  used  in  two  of  the
three  patients  who  died  from  carotid  artery  rupture.  Both
patients  presented  partial  necrosis  of  the  ﬂap  secondary
to  superinfection  by  anaerobic  bacteria.  This  infection  was
probably  facilitated  by  preoperative  irradiation,  which  is
known  to  modify  the  commensal  bacterial  ﬂora  of  the  oral
cavity.
Oncological  results  were  poor,  but  strictly  comparable
to  those  reported  in  the  literature  [8—10]. The  mean  local
control  rate  was  45%  (39—50).  The  mean  3-year  survival  rate
was  26%  (22%—34%)  and  the  mean  5-year  survival  rate  was
19%  (16%—23%).  The  three  leading  causes  of  death  in  the
present  series  were  local  and/or  lymph  node  recurrence
and  metachronous  cancer.  In  published  series,  the  lead-
ing  cause  of  failure  is  local  recurrence  [20]. In  our  series,
local  recurrence  was  largely  due  to  the  high  histologically
incomplete  (40%)  or  borderline  (21%)  resection  rate,  while
resection  was  considered  to  be  complete  intraoperatively.e15
he  macroscopic  appearance  of  irradiated  tissues  makes  it
ifﬁcult  to  assess  the  limits  between  pathological  tissue
nd  healthy  tissue  and  frozen  section  examination  of  sur-
ical  margins  does  not  appear  to  be  sufﬁciently  reliable  to
vercome  this  difﬁculty.  Resection  is  even  more  difﬁcult  for
arge,  ulcerated  tumours  situated  in  the  glossotonsillar  sul-
us  and  base  of  the  tongue.  In  our  series,  this  parameter
ccounted  for  the  fact  that:
 two  third  of  invaded  or  borderline  margins  involved  mus-
cle  and  were  situated  in  the  posterior  and  deep  parts  of
the  base  of  the  tongue;
 the  site  of  tumour  recurrence  is  a  major  determinant  of
survival.
Recurrences  situated  in  the  glossotonsillar  sulcus  and  the
ase  of  the  tongue  have  a  poorer  prognosis.  Gehanno  et  al.,
arsons  et  al.  and  Rodriguez  et  al.  have  already  emphasized
he  impact  of  tumour  site  on  survival  [9,11,22].  Lymph  node
ecurrence  is  largely  due  to  the  high  rate  (64%)  of  capsu-
ar  effraction  in  pN+  tumours.  In  the  presence  of  pejorative
istoprognostic  factors  (R1,  pN+),  some  authors  have  pro-
osed  re-irradiation,  initially  limited  to  brachytherapy  [23],
hen  associated  with  chemotherapy  [6,24]. However,  not  all
atients  are  suitable  for  these  treatments.  In  our  series,  less
han  8%  of  patients  were  eligible  for  this  treatment.  The  gen-
ral  state  and  the  poor  trophicity  of  irradiated  tissues  are
he  two  main  limiting  elements,  especially  as  re-irradiation
ccentuates  late  toxicity  and  is  associated  with  signiﬁcantly
oorer  functional  results  (swallowing  and  breathing).  A  high
ate  of  metachronous  cancers  was  reported  in  this  series:
1.5%  of  the  initial  sample.  Management  of  metachronous
ancers  remains  difﬁcult  and  very  few  patients  are  eligible
or  curative  treatment.
As  for  the  majority  of  authors,  tumour  size  is  a  major
eterminant  of  survival  [9,11], with  a  better  prognosis  for
mall  tumours  (rT1-T2).  Similarly,  the  prognosis  is  better
hen  the  interval  between  irradiation-salvage  surgery  is
reater  than  6  months  [9].  These  two  parameters  were  the
redominant  prognostic  factors  for  survival  on  multivariate
nalysis.
onclusion
he  postoperative  course  of  salvage  surgery  for  cancer  of  the
ateral  pharyngeal  wall  is  associated  with  high  morbidity  and
oor  survival.  These  elements  must  be  taken  into  account
hen  selecting  patients  eligible  for  ﬁrst-line  radiotherapy
or  oropharyngeal  cancer.
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